1 George Washington University Hospital, 900 23rd St NW, Washington, DC 20037.
2 New York University Langone Medical Center, New York, NY.
AJR Am J Roentgenol. 2018 Mar;210(3):583-592. doi: 10.2214/AJR.17.18294. Epub 2018 Jan 30.
The purpose of this study is to compare dose-length product (DLP)-based calculation of effective dose (ED) with Monte Carlo simulation organ-based calculation of effective dose (ED) in 16- and 64-MDCT examinations, with the use of clinical examinations with automatic tube current modulation.
Dose data were obtained from 50 consecutive unenhanced head CT examinations, unenhanced chest CT examinations, and unenhanced and contrast-enhanced abdominopelvic CT examinations performed using 16- and 64-MDCT scanners, as well as from 50 pulmonary CT angiography (CTA) examinations performed using a 64-MDCT scanner and 31 pulmonary CTA examinations performed using a 16-MDCT scanner. The ED and the mean patient effective diameter were calculated using commercially available software. The ED was also calculated. Both the mean difference and percentage difference between ED and ED were calculated, and they were statistically compared according to patient sex, type of examination performed, and type of scanner used.
ED significantly underestimated the ED by 0.3 mSv (19%) for men who underwent unenhanced head CT, 0.5 mSv (29%) for women who underwent unenhanced head CT, 0.9-1.4 mSv (9-13%) for men who underwent chest CT, and 4.7-4.8 mSv (39%) for women who underwent chest CT (p < 0.001). The ED overestimated the ED by 1.9-2.0 mSv (12-14%) for men who underwent abdominopelvic CT (p < 0.001), with no significant difference noted for women who underwent abdominopelvic CT's. No significant difference was noted in the percentage difference in ED between the 16- and 64-MDCT scanners (p ≥ 0.13).
ED underestimates ED, the reference standard for dose calculation, by 19-39% in unenhanced head CT examinations and, among women, in chest CT examinations. ED deviates from ED by less than 15% for chest CT examinations of men and for abdominopelvic CT. These differences can be attributed to variable patient body habitus, automatic tube current modulation, and sex-neutral k-coefficients, and they should be considered when calculating ED, particularly in women.
本研究旨在比较基于剂量长度乘积(DLP)的有效剂量(ED)计算与使用自动管电流调制的 16 层和 64 层 MDCT 检查中的蒙特卡罗模拟器官基有效剂量(ED)计算,同时使用临床检查。
从 50 例连续进行的非增强头部 CT 检查、非增强胸部 CT 检查、非增强和增强腹部盆腔 CT 检查以及 50 例 64 层 MDCT 扫描进行的肺部 CT 血管造影(CTA)检查和 31 例 16 层 MDCT 扫描进行的肺部 CTA 检查中获得剂量数据。使用市售软件计算 ED 和患者平均有效直径。还计算了 ED,并且根据患者性别、进行的检查类型和使用的扫描仪类型,计算了 ED 与 ED 之间的平均差异和百分比差异,并进行了统计学比较。
对于接受非增强头部 CT 的男性,ED 显著低估 ED 0.3 mSv(19%),对于接受非增强头部 CT 的女性,ED 低估 0.5 mSv(29%),对于接受胸部 CT 的男性,ED 低估 0.9-1.4 mSv(9-13%),对于接受胸部 CT 的女性,ED 低估 4.7-4.8 mSv(39%)(p<0.001)。对于接受腹部盆腔 CT 的男性,ED 高估 ED 1.9-2.0 mSv(12-14%)(p<0.001),而对于接受腹部盆腔 CT 的女性,ED 无显著差异。16 层和 64 层 MDCT 扫描仪之间的 ED 百分比差异无显著差异(p≥0.13)。
ED 在非增强头部 CT 检查中低估 ED,ED 是剂量计算的参考标准,女性胸部 CT 检查中低估 ED,男性胸部 CT 检查中 ED 与 ED 偏差小于 15%,女性腹部盆腔 CT 检查中 ED 与 ED 偏差小于 15%。这些差异可归因于可变的患者体型、自动管电流调制和性别中性的 k 系数,在计算 ED 时应考虑这些差异,尤其是在女性中。